Biosensors Market Size, Share, and Trends 2025 to 2034

Biosensors Market Size and Forecast 2025 to 2034

The global biosensors market size was calculated at USD 30.71 billion in 2024 and is predicted to increase from USD 33.16 billion in 2025 to approximately USD 61.29 billion by 2034, expanding at a CAGR of 7.07% from 2025 to 2034.

Biosensors Market Key Takeaways

• In terms of revenue, the market is valued at $33.16 billion in 2025.
• It is projected to reach $61.29 billion by 2034.
• The market is expected to grow at a CAGR of 7.07% from 2025 to 2034.
• North America has dominated the biosensors market in 2024 with revenue share of 39.46%.
• By Technology, the electrochemical segment has captured revenue share of 70.09% in 2024.
• By Application, the medical segment has generated largest revenue share of around 65.79% in 2024.
• By End User, the point of care testing segment has accounted revenue share of 47% in 2024.

U.S. Biosensors Market Size and Growth 2025 to 2034

The U.S. biosensors market size was exhibited at USD 10.12 billion in 2024 and is projected to be worth around USD 19.44 billion by 2034, growing at a CAGR of 6.67% from 2025 to 2034.

North America dominated the biosensors market in 2024 with 39.46% revenue share. The factors such as rising prevalence of chronic disorders, growing health awareness among the consumers, expansion of healthcare sector, and technological advancements are driving the growth of biosensors market in the region. In addition, the biosensors market in North America region is being driven by growing healthcare expenditures. Moreover, market players are adopting various strategies for increasing their market share in biosensors market. For example, Nova Biomedical got Food and Drug Administration (FDA) approval for its Stat Profile Prime Plus device in point of care use in 2020.

North America Top countries

Pioneering Precision Sensing with Innovation

The U.S. is the central hub of biosensor innovation, housing major players and advanced regulatory support. Emerging market with growing adoption in agricultural and environmental biosensing. Manufacturing base for biotech and biosensor assembly due to tax incentives. It holds a leading position in the biosensor market, driven by strong R&D infrastructure, a robust healthcare system, and favorable reimbursement policies.

Canada has strong academic research backing and an increasing focus on portable diagnostics, driven by research-led advancements, particularly in biopharma and healthcare diagnostics. Canada benefits significantly from the presence of globally renowned biosensor manufacturers and frequent technological breakthroughs in diagnostics and point-of-care testing.

Europe, on the other hand, is expected to develop at the fastest rate during the forecast period. The UK dominates the biosensors market in Europe region. In 2018, the International Diabetes Federation estimated that 32.7 million persons in Europe had diabetes. Thus, the growing prevalence of life related diseases are driving the demand for biosensors in Europe region. In addition, growing geriatric population is also driving the growth of biosensors market in this region.

• North America biosensors market size was valued at USD 12.12 billion in 2024 and it is expected to surpass around USD 23.64 billion by 2034.
• Europe biosensors market size was accounted for USD 7.31 billion in 2024 and is expanding at a CAGR of 6.9%.
• Asia Pacific biosensors market size was exhibited at USD 6.24 billion in 2024 and is projected to hit USD 12.74 billion by 2034.

Europe Major contributing factors

Empowering Sensing with Sustainability and Safety

• Growing need for non-invasive diagnostics in public health.
• Regulatory encouragement for green and sustainable technologies.
• Expansion of point-of-care devices for rural and ageing populations.
• Increased funding for biotech start-ups and research institutions.
• Rising adoption of wearable biosensors for chronic disease monitoring.
• Rapid technological expansion and adoption of biosensors, especially in environmental monitoring, food safety, and chronic disease management.
• Stringent regulatory standards and environmental policies are pushing industries to adopt biosensing solutions for real-time analysis.

Market overview

Worldwide product highlights

Technological advancements in the market

• Nano-enabled biosensors: Enhanced sensitivity using nanomaterials like graphene and gold nanoparticles. 
• Wearable biosensors: For continuous health monitoring through smartwatches and skin patches. 
• Point-of-care (POC) devices: Portable biosensors allowing immediate diagnostics at clinics or in the field. 
• Label-free detection technologies: Reducing testing time and costs by eliminating reagent steps. 
• Multiplexing capabilities: Detecting multiple analytes simultaneously in a single assay.

Biosensors Market Growth Factors

The biosensors are used as medical devices to detect biological substances. The growth of global biosensors market is being driven by the rising prevalence of chronic disorders. According to World Health Organization (WHO), the incidence of chronic diseases is growing at a rapid pace. In addition, the adoption of innovative technologies such as artificial intelligence and internet of things are paving way for the growth opportunities for the global biosensors market.

The biosensors are widely used in healthcare sector for sensing, detecting, and monitoring various kind of disorders among the people. One of the key factors boosting the growth of global biosensors market is rising prevalence of diabetes all around the globe. The biosensors are used to detect blood glucose levels which are directly utilized for the detection of diabetes on a large scale. Thus, this factor is supporting the growth and development of global biosensors market.

The growth of the global biosensors market is being restricted by the stringent government regulations and reimbursement policies. In addition, the adoption of new and latest technologies is quite slow in low- and middle-income nations. This factor is hampering the growth of the biosensors market.

Market Scope

Technology Insights

The electrochemical segment garnered revenue share of around 70.09% in 2024. The electrochemical technology is quite advantageous than other types of technologies. The electrochemical biosensors are low in cost and needs low power to operate. As a result, major market players utilize electrochemical technology while manufacturing biosensors. This factor is driving demand for biosensors in the global market.

The optical segment is fastest growing segment of the biosensors market in 2024. The optical biosensors are widely used in the healthcare industry. The optical biosensors are beneficial in nature as compared to traditional biosensors. These types of biosensors help in quick sample preparation and picks biological element by sensing the molecules. Thus, the market for optical biosensors is expected to grow in the near future.

Global Biosensors Market Revenue, by Technology (USD Million)

Application Insights

The medical segment accounted largest revenue share in 2024. The biosensors are widely utilized in the medical sector for detecting and diagnosing various disorders. This includes blood glucose tracking, pregnancy monitoring, and cholesterol testing. The biosensors are one of the important tools for detection of cancer and diabetes. Thus, the rising prevalence of such diseases is boosting the growth of global biosensors market.

The agriculture biosensors segment is fastest growing segment of the biosensors market in 2024. The biosensors in agriculture industry are gaining popularity nowadays. The biosensors help farmers to identify wide number of funguses in crops. The biosensors also detect bacteria in the farms. This is helping farmers to maximize their yield. The condition of soil is also determined through biosensors. Thus, biosensors’ demand is growing at a rapid pace for agriculture purpose.

Global Biosensors Market Revenue, by Application ( USD Million)

End User Insights

The point of care testing segment hit market share of 47.15% in 2024. The biosensors in the point of care testing market are growing due to the technological advancements. The market players are adopting innovative technologies for manufacturing of biosensors. The biosensors are used for monitoring saliva, urine, and blood of the human body. The results are accurate and precise in nature for detecting various diseases. In addition, growing research and development activities are also driving the growth of the segment.

The food industry segment is fastest growing segment of the biosensors market in 2024. The biosensors are largely used in the food processing sectors. The bacteria are detected in food preservatives. Thus, the growing demand for high quality food products is also driving the demand for biosensors in the food industry.

Global Biosensors Market Revenue, by End Use (USD Million)

Biosensors Market Companies

• Bio-Rad Laboratories Inc.
• Abbott Laboratories
• Biosensors International Group Ltd.
• DuPont Biosensor Materials
• Pinnacle Technologies Inc.
• Johnson & Johnson
• Molecular Devices Corporation
• QTL Biodetection LLC
• TDK Corporation
• Zimmer & Peacock AS

Recent Developments

• In May 2025, new Wearable 'The Ring' set to revolutionise emotional connectivity for couples. A groundbreaking wearable device named The Ring is currently under development, aiming to enhance the emotional connection between couples through advanced technology. Designed with embedded biosensors, this smart ring monitors the wearer's emotional states by analysing physiological signals. 
• Roche Diagnostics released a fast antibody test for SARS-CoV-2 in July 2020. SD Biosensors Inc. is collaborating on this release. The SARS-CoV-2 fast antibody test is intended for use in point of care settings and it is expected to expand its client base.
• The glucose saliva biosensor was released by IQ Group Global in February 2019. This innovative device or gadget is one of the few non invasive or minimally invasive glucose saliva-based testing technologies available for diabetes treatment that does not require blood collection. The saliva-based glucose test is being developed to help the world’s 425 million diabetics live healthier lives.
• Libre Sense glucose sports biosensors will be available in Europe in September 2020, according to Abbott Laboratories. The device is based on the world’s most advanced CGM technology which will aid athletes in better understanding the relationship between blood glucose levels and sports performance thereby expanding the company’s customer base.
• Medtronic’s MiniMed 770G hybrid closed loop system was approved by the FDA in September 2020. The latest insulin pump system has the company’s latest and most advanced SmartGuard technology which is also found in the MiniMed 670G system as well as smartphone communication and age identification down to 2 years old.

Segments Covered in the Report

By Technology

• Thermal
• Electrochemical
• Piezoelectric
• Optical

By Application

• Medical
• Cholesterol
• Blood glucose
• Blood gas analyzer
• Pregnancy testing
• Drug discovery
• Infectious disease
• Food Toxicity
• Bioreactor
• Agriculture
• Environment
• Others

By End User

• Home Healthcare Diagnostics
• PoC Testing
• Food Industry
• Research Laboratories
• Security and Bio-defense

By Type

• Cholesterol
• Blood Glucose
• Blood Gas Analyzer
• Pregnancy Testing
• Drug Discovery

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa